Press release
De-Identified Health Data Market Trends Support A 11.7% CAGR Outlook Through The Forecast Period
De-Identified Health Data Market
Projected Growth and Scale of the De-Identified Health Data Market
The market for de-identified health data is anticipated to experience significant expansion in the coming years. By 2030, its value is expected to reach $16.07 billion, growing at a compound annual growth rate (CAGR) of 11.7%. This surge is driven by factors such as the increasing use of AI-powered health insights, growing investments in precision medicine research, the expansion of analytics tied to value-based care, rising demand for secure health data exchange, and broader adoption of real-world evidence in regulatory decision-making. Key trends forecasted include the rise of large-scale de-identified data platforms, enhanced real-world evidence analytics, privacy-focused data sharing models, longitudinal patient data studies, and integration of diverse healthcare datasets.
The de-identified health data market size has grown rapidly in recent years. It will grow from $9.2 billion in 2025 to $10.31 billion in 2026 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to increasing adoption of electronic health records, rising demand for population health analytics, expansion of clinical research databases, growing focus on patient privacy compliance, increasing availability of structured healthcare data.
Download a free sample of the de-identified health data market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28191&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Key Drivers Propelling the De-Identified Health Data Market Forward
One important force behind the market's growth is the growing reliance on AI-driven tools that provide deeper health insights. These technologies enable more precise and personalized approaches to healthcare, supporting better outcomes across various patient populations.
Additionally, increasing investments in precision medicine are boosting demand for high-quality, de-identified data. Precision medicine research depends heavily on vast health datasets that protect patient privacy while enabling detailed analysis, leading to more targeted and effective treatments.
Leading Companies Making an Impact in the De-Identified Health Data Market
Several prominent organizations are shaping the future of this sector, including UnitedHealth Group Incorporated, Oracle Corporation, IQVIA Holdings Inc, ICON Public Limited Company, Datavant Inc, Premier Inc., iMerit Technology Services Pvt. Ltd., Tempus Labs Inc., Medidata Solutions Inc., Veradigm Inc., Flatiron Health, Merative LP, Komodo Health Inc., Shaip Inc., Truveta Inc., Evidation Health Inc., TriNetX Inc., Clarify Health Solutions Inc., Akrivia Health Ltd., and Gradient Health Inc.
A notable development occurred in July 2025 when Datavant Inc., a US-based health IT company, acquired Aetion Inc. Although the financial terms were not disclosed, this acquisition aims to bolster Datavant's real-world evidence capabilities by incorporating Aetion's advanced analytics platform. This integration offers life sciences and healthcare organizations an end-to-end solution to generate regulatory-grade insights from de-identified health data. Aetion is known for its real-world evidence platform services that process de-identified health data through tools like Aetion Generate.
View the full de-identified health data market report:
https://www.thebusinessresearchcompany.com/report/de-identified-health-data-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Emerging Trends and Innovations in the De-Identified Health Data Industry
Market leaders are increasingly focusing on creating sophisticated solutions such as real-world biomarker coverage applications that support data-driven healthcare decisions. These applications analyze de-identified patient data to track biomarker patterns and treatment effectiveness across diverse populations outside the constraints of clinical trials, helping researchers and clinicians understand disease trends and patient responses.
For example, in July 2025, Datma Inc., a US healthcare technology firm, introduced the Federated Biomarker Explorer. This free tool enables pharmaceutical teams to rapidly validate biomarker coverage within Datma's federated data network. The application provides aggregate insights at the cohort level, allowing users to assess coverage efficiently without contracts or IT support. It also supports secure integration of external data for overlap analysis and enables early-stage feasibility assessments with clinical and demographic filters, helping organizations confirm if necessary patient data is present before committing resources.
Detailed Segmentation of the De-Identified Health Data Market
This market is categorized into several important segments for better understanding and analysis:
1) By Type: Clinical Data, Genomic Data, Patient Demographics, Prescription Data, Hospital and Provider Data, Pharmacogenomic Data
2) By Application: Clinical Research and Trials, Public Health, Precision Medicine, Health Economics and Outcomes Research (HEOR), Population Health Management, Drug Discovery and Development, Healthcare Quality Improvement, Insurance Underwriting and Risk Assessment, Other Applications
3) By End-User: Pharmaceutical Companies, Biotechnology Firms, Healthcare Providers, Insurance Companies or Healthcare Payers, Research Institutions, Government Agencies, Other End-Users
Further breakdown of subsegments includes:
- Clinical Data: Electronic Health Records, Medical Imaging Data, Laboratory Test Results, Surgical Reports, Pathology Reports, Vital Signs Measurements
- Genomic Data: Whole Genome Sequencing, Exome Sequencing, Single Nucleotide Polymorphisms, Gene Expression Profiles, Epigenetic Data
- Patient Demographics: Information on Age, Gender, Ethnicity, Location, Socioeconomic Status, Marital Status
- Prescription Data: Medication Orders, Dosage Details, Refill History, Drug Allergies, Pharmacy Dispensation Records
- Hospital and Provider Data: Provider Performance Metrics, Care Outcomes, Billing and Claims Data, Resource Utilization
- Pharmacogenomic Data: Gene-Drug Interactions, Adverse Drug Reactions, Personalized Therapy Responses, Variations in Drug Efficacy
Together, these segments and trends outline a comprehensive and rapidly evolving market that is increasingly essential to the future of healthcare research, policy, and patient care management.
Our latest 2026 market reports provide expanded strategic and visual intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, together with updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release De-Identified Health Data Market Trends Support A 11.7% CAGR Outlook Through The Forecast Period here
News-ID: 4605514 • Views: …
More Releases from The Business Research Company
CRISPR Technology Market Outlook Highlights Strategic Opportunities Across The I …
The evolving landscape of gene editing is rapidly transforming biotechnology and medicine, with CRISPR technology at the forefront of this revolution. This market is witnessing remarkable expansion driven by breakthroughs in gene editing therapies and innovative agricultural applications. Let's explore the current market size, key players, notable trends, and the segmentation shaping the future of the CRISPR technology industry.
Projected Market Size of the CRISPR Technology Industry by 2030
The…
Craniomaxillofacial (CMF) Distraction System Market Study Explores Industry Grow …
The craniomaxillofacial (CMF) distraction system market is on track for notable expansion in the coming years. Driven by technological advancements and evolving surgical practices, this segment is poised to experience significant growth as more patients benefit from improved reconstructive procedures. Let's explore the market's projected size, key contributors, emerging trends, and segmentation to understand its future trajectory.
Projected Market Size and Growth for the Craniomaxillofacial Distraction System Market
The market…
COVID-19 Saliva Screening Test Potential Market Research Reveals Path To $6.46 B …
The COVID-19 saliva screening test market is positioned for significant expansion in the coming years. Growing emphasis on public health readiness, the rise of decentralized testing, and increased demand for large-scale, cost-effective screening methods are key factors driving this upward trend. Advancements in saliva-based diagnostic technology also contribute to the promising outlook for this sector.
Projected Market Value and Growth Trajectory of the COVID-19 Saliva Screening Test Potential Market
The…
Dental Caries Treatment Market Research Reveals Strong 5.3% CAGR Outlook Through …
The dental caries treatment market is set for notable expansion as global awareness of oral health continues to rise. Driven by technological advancements and increased access to dental care, this sector is evolving rapidly to meet the demands of both patients and practitioners. Below, we delve into the market's forecast, key players, influential trends, and comprehensive segmentation.
Forecasted Market Size and Growth Trajectory of the Dental Caries Treatment Market
The…
More Releases for Data
Data Catalog Market: Serving Data Consumers
Data Catalog Market size was valued at US$ 801.10 Mn. in 2022 and the total revenue is expected to grow at a CAGR of 23.2% from 2023 to 2029, reaching nearly US$ 3451.16 Mn.
Data Catalog Market Report Scope and Research Methodology
The Data Catalog Market is poised to reach a valuation of US$ 3451.16 million by 2029. A data catalog serves as an organized inventory of an organization's data assets, leveraging…
Big Data Security: Increasing Data Volume and Data Velocity
Big data security is a term used to describe the security of data that is too large or complex to be managed using traditional security methods. Big data security is a growing concern for organizations as the amount of data generated continues to increase. There are a number of challenges associated with securing big data, including the need to store and process data in a secure manner, the need to…
HOW TO TRANSFORM BIG DATA TO SMART DATA USING DATA ENGINEERING?
We are at the cross-roads of a universe that is composed of actors, entities and use-cases; along with the associated data relationships across zillions of business scenarios. Organizations must derive the most out of data, and modern AI platforms can help businesses in this direction. These help ideally turn Big Data into plug-and-play pieces of information that are being widely known as Smart Data.
Specialized components backed up by AI and…
Test Data Management (TDM) Market - test data profiling, test data planning, tes …
The report categorizes the global Test Data Management (TDM) market by top players/brands, region, type, end user, market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
This report studies the global market size of Test Data Management (TDM) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption…
Data Prep Market Report 2018: Segmentation by Platform (Self-Service Data Prep, …
Global Data Prep market research report provides company profile for Alteryx, Inc. (U.S.), Informatica (U.S.), International Business Corporation (U.S.), TIBCO Software, Inc. (U.S.), Microsoft Corporation (U.S.), SAS Institute (U.S.), Datawatch Corporation (U.S.), Tableau Software, Inc. (U.S.) and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY…
Long Term Data Retention Solutions Market - The Increasing Demand For Big Data W …
Data retention is a technique to store the database of the organization for the future. An organization may retain data for several different reasons. One of the reasons is to act in accordance with state and federal regulations, i.e. information that may be considered old or irrelevant for internal use may need to be retained to comply with the laws of a particular jurisdiction or industry. Another reason is to…
